Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Odorant receptor 31 (Or31) is a specialized chemosensory receptor found in insects, most notably in mosquito species such as Aedes aegypti and Anopheles gambiae. It belongs to the insect odorant receptor (OR) family, which functions as a heteromeric, non-selective cation channel in complex with the highly conserved co-receptor Orco. Or31 is primarily expressed in the olfactory receptor neurons of the antennae and is responsible for detecting specific volatile compounds, such as (E)-beta-farnesene (EBF) and geranyl acetate. Activation of Or31 by these ligands, particularly EBF (a component of pyrethrum), triggers spatial repellency and avoidance behaviors in mosquitoes. This makes Or31 a significant target for the development of novel insect repellents and vector control strategies aimed at reducing the transmission of infectious diseases like malaria, dengue, and Zika. In addition to agonists, research has identified allosteric antagonists like tryptamine and tyramine that can inhibit the receptor's function, providing further avenues for behavioral manipulation. The receptor's conservation across major disease-transmitting mosquito genera underscores its potential as a broad-spectrum target for public health interventions.
Agonism of the Or31/Orco heteromeric complex triggers spatial repellency and avoidance behavior in insects; allosteric antagonism inhibits odorant-induced activation.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Odorant receptor 31 (Or31).